Literature DB >> 3878241

Epidermal T lymphocytes and dendritic cells in chronic plaque psoriasis: the effects of PUVA treatment.

B S Baker, A F Swain, C E Griffiths, J N Leonard, L Fry, H Valdimarsson.   

Abstract

The numbers and HLA-DR expression of T cell subsets and dendritic cells in chronic psoriatic plaques were compared to previously reported findings in spontaneously resolving guttate lesions, and the effects of PUVA treatment on these cell populations studied. The chronic lesions showed a similar T helper/T suppressor (TH/TS) ratio (0.66 +/- 0.10) to resolving guttate lesions. However, in contrast to the resolving lesions which do not contain activated epidermal TH cells, a substantial proportion of the TH cells in the persistent plaques were DR+. Moreover, these persistent lesions contained markedly increased numbers of DR+ dendritic cells, approximately 20% of which were T6 negative. PUVA-induced resolution of chronic lesions was associated with depletion of epidermal TH and TS cells, and a subsequent reduction in DR+ dendritic cells. In each patient the rate of disappearance of both cell types correlated with the rate of resolution. Furthermore, the epidermal T cell depletion preceded the onset of clinical improvement. In contrast, significant reduction of the dendritic cells was generally not observed until the lesions were largely resolved. Dendritic cells decreased faster in uninvolved than in lesional skin and to a subnormal level. Dermal T cells also decreased during PUVA therapy but this did not show any obvious correlation with resolution of the lesions. Blood T cell levels were not significantly affected by the treatment. These findings support the concept that the initiation and maintenance of the psoriatic process requires activation of TH cells in the epidermis via interaction with antigen presenting cells. Furthermore PUVA treatment may clear psoriasis by interfering with such a mechanism through its effects on T lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3878241      PMCID: PMC1577286     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  23 in total

1.  Langerhans cells: involvement in the pathogenesis of mycosis fungoides.

Authors:  G Rowden; M G Lewis
Journal:  Br J Dermatol       Date:  1976-12       Impact factor: 9.302

2.  In situ identification of lymphoreticular cells in benign and malignant infiltrates by membrane receptor sites.

Authors:  G Stingl; K Wolff; E Diem; G Baumgartner; W Knapp
Journal:  J Invest Dermatol       Date:  1977-08       Impact factor: 8.551

3.  Characterization of mononuclear cell infiltrates in psoriatic lesions.

Authors:  J R Bjerke; H K Krogh; R Matre
Journal:  J Invest Dermatol       Date:  1978-11       Impact factor: 8.551

4.  Lymphocyte mitogenic factor in man.

Authors:  R N Maini; A D Bryceson; R A Wolstencroft; D C Dumonde
Journal:  Nature       Date:  1969-10-04       Impact factor: 49.962

5.  T lymphocyte E rosette function during photochemotherapy (PUVA) of psoriasis.

Authors:  M Haftek; W Gliński; S Jabłońska; S Obałek
Journal:  J Invest Dermatol       Date:  1979-05       Impact factor: 8.551

6.  Lymphocyte-mediated activation of fibroblast proliferation and collagen production.

Authors:  S M Wahl; L M Wahl; J B McCarthy
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

7.  Epidermal T lymphocytes and HLA-DR expression in psoriasis.

Authors:  B S Baker; A F Swain; L Fry; H Valdimarsson
Journal:  Br J Dermatol       Date:  1984-05       Impact factor: 9.302

8.  Oral methoxsalen photochemotherapy for the treatment of psoriasis: a cooperative clinical trial.

Authors:  J W Melski; L Tanenbaum; J A Parrish; T B Fitzpatrick; H L Bleich
Journal:  J Invest Dermatol       Date:  1977-06       Impact factor: 8.551

9.  Inhibition of cell mediated immune responses by 8-methoxypsoralen and long-wave ultraviolet light: a possible explanation for the clinical effects of photoactivated psoralen.

Authors:  V B Morhenn; C J Benike; E G Engleman
Journal:  J Invest Dermatol       Date:  1980-09       Impact factor: 8.551

10.  Lymphokine enhances the expression and synthesis of Ia antigens on cultured mouse peritoneal macrophages.

Authors:  R M Steinman; N Nogueira; M D Witmer; J D Tydings; I S Mellman
Journal:  J Exp Med       Date:  1980-11-01       Impact factor: 14.307

View more
  17 in total

Review 1.  Immunological mechanisms involved in psoriasis.

Authors:  C E Griffiths; J J Voorhees
Journal:  Springer Semin Immunopathol       Date:  1992

2.  Soluble IL-2 receptor and CD25 cells in psoriasis: effects of cyclosporin A and PUVA therapy.

Authors:  J I Duncan; C Horrocks; A D Ormerod; A V Powles; P H Whiting; L Fry; A W Thomson
Journal:  Clin Exp Immunol       Date:  1991-08       Impact factor: 4.330

3.  Epidermal lymphocyte chemotactic factor specifically attracts OKT4-positive lymphocytes.

Authors:  C Zachariae; T Ternowitz; C G Larsen; V Nielsen; K Thestrup-Pedersen
Journal:  Arch Dermatol Res       Date:  1988       Impact factor: 3.017

4.  Psoriasis.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1986-07-26

5.  Influence of systemic cyclosporin A on interleukin-2 and epidermal growth factor receptor expression in psoriatic skin lesions.

Authors:  A Horroccks; A D Ormerod; J I Duncan; A W Thomson
Journal:  Clin Exp Immunol       Date:  1989-11       Impact factor: 4.330

6.  Histopathological and immunohistochemical changes in psoriatic skin during peptide T treatment.

Authors:  T Talme; B L Rozell; K G Sundqvist; L Wetterberg; J A Marcusson
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

7.  Cytokine expression in psoriatic skin lesions during PUVA therapy.

Authors:  A K Olaniran; B S Baker; D G Paige; J J Garioch; A V Powles; L Fry
Journal:  Arch Dermatol Res       Date:  1996-07       Impact factor: 3.017

Review 8.  Immunopathogenic mechanisms in psoriasis.

Authors:  J E Gudjonsson; A Johnston; H Sigmundsdottir; H Valdimarsson
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

9.  Peripheral blood T cell responses to keratin peptides that share sequences with streptococcal M proteins are largely restricted to skin-homing CD8(+) T cells.

Authors:  A Johnston; J E Gudjonsson; H Sigmundsdottir; T J Love; H Valdimarsson
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

10.  Immunohistochemical markers for arthritis in psoriasis.

Authors:  D J Veale; L Barnes; S Rogers; O FitzGerald
Journal:  Ann Rheum Dis       Date:  1994-07       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.